Data Insights

Trabectedin by Pharma Mar for Round Cell Liposarcoma: Likelihood of Approval

Trabectedin is under clinical development by Pharma Mar and currently in Phase II for Round Cell Liposarcoma. According to GlobalData,...

Data Insights

Trabectedin by Pharma Mar for Myxoid Liposarcoma: Likelihood of Approval

Trabectedin is under clinical development by Pharma Mar and currently in Phase II for Myxoid Liposarcoma. According to GlobalData, Phase...

Data Insights

Trabectedin by Pharma Mar for Dedifferentiated Liposarcoma: Likelihood of Approval

Trabectedin is under clinical development by Pharma Mar and currently in Phase II for Dedifferentiated Liposarcoma. According to GlobalData, Phase...

Data Insights

Trabectedin by Pharma Mar for Soft Tissue Sarcoma: Likelihood of Approval

Trabectedin is under clinical development by Pharma Mar and currently in Phase II for Soft Tissue Sarcoma. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - Trabectedin in Soft Tissue Sarcoma

Data Insights

Trabectedin by Pharma Mar for Chondrosarcoma: Likelihood of Approval

Trabectedin is under clinical development by Pharma Mar and currently in Phase II for Chondrosarcoma. According to GlobalData, Phase II...

Likelihood of Approval and Phase Transition Success Rate Model - Trabectedin in Chondrosarcoma

Data Insights

Trabectedin by Johnson & Johnson for Ewing Sarcoma: Likelihood of Approval

Trabectedin is under clinical development by Johnson & Johnson and currently in Phase II for Ewing Sarcoma. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - Trabectedin in Ewing Sarcoma

Data Insights

Trabectedin by Pharma Mar for Osteosarcoma: Likelihood of Approval

Trabectedin is under clinical development by Pharma Mar and currently in Phase II for Osteosarcoma. According to GlobalData, Phase II...

Likelihood of Approval and Phase Transition Success Rate Model - Trabectedin in Osteosarcoma

Data Insights

Trabectedin by Pharma Mar for Ovarian Cancer: Likelihood of Approval

Trabectedin is under clinical development by Pharma Mar and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Trabectedin in Ovarian Cancer